St. Jude Medical Given Average Recommendation of “Hold” by Brokerages (NYSE:STJ)
Shares of St. Jude Medical (NYSE:STJ) have earned an average rating of “Hold” from the twenty-two brokerages that are currently covering the company, AnalystRatingsNetwork reports. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and ten have assigned a buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $69.67.
A number of analysts have recently weighed in on STJ shares. Analysts at Sterne Agee initiated coverage on shares of St. Jude Medical in a research note on Tuesday, July 29th. They set a “neutral” rating and a $74.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of St. Jude Medical in a research note on Thursday, July 17th. They now have a $81.00 price target on the stock, up previously from $74.00. Finally, analysts at Zacks reiterated a “neutral” rating on shares of St. Jude Medical in a research note on Thursday, July 17th. They now have a $71.00 price target on the stock.
St. Jude Medical (NYSE:STJ) traded up 0.87% on Monday, hitting $65.11. 139,064 shares of the company’s stock traded hands. St. Jude Medical has a 52 week low of $49.94 and a 52 week high of $71.90. The stock has a 50-day moving average of $66.2 and a 200-day moving average of $65.57. The company has a market cap of $18.536 billion and a price-to-earnings ratio of 20.80.
St. Jude Medical (NYSE:STJ) last posted its quarterly earnings results on Wednesday, July 16th. The company reported $1.02 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.00 by $0.02. The company had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the prior year, the company posted $0.96 earnings per share. The company’s quarterly revenue was up 3.2% on a year-over-year basis. On average, analysts predict that St. Jude Medical will post $4.00 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 1.67%. The ex-dividend date is Friday, September 26th.
St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.
Receive News & Ratings for St Jude Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St Jude Medical Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.